Suchergebnisse - "Izumi, Shinyu"

PubPharm (25)

1

Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy

enthalten in: Scientific reports | 2023

von Kataoka, K. | Oda, K. | Takizawa, H. | +20

2

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis : The ISABELA 1 and 2 Randomized Clinical Trials

enthalten in: JAMA | 2023

von Maher, T. | Ford, P. | Brown, K. | +125

CommentIn: JAMA. 2023 May 9;329(18):1554-1555. - PMID 37159046

3

Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification : clinical features with a progressive phenotype

enthalten in: BMJ open respiratory research | 2022

von Nishioka, Y. | Toyoda, Y. | Egashira, R. | +32

4

Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19

enthalten in: Scientific reports | 2022

von Nishida, N. | Sugiyama, M. | Kawai, Y. | +14

5

Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR

enthalten in: Infectious diseases (London, England) | 2021

von Tsujimoto, Y. | Terada, J. | Kimura, M. | +21

6

Corticosteroids for hospitalized patients with mild to critically-ill COVID-19 : a multicenter, retrospective, propensity score-matched study

enthalten in: Scientific reports | 2021

von Ikeda, S. | Misumi, T. | Izumi, S. | +39

7

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure

enthalten in: Frontiers in immunology | 2021

von Khor, S. | Omae, Y. | Nishida, N. | +10

8

Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial

enthalten in: American journal of respiratory and critical care medicine | 2020

von Kondoh, Y. | Azuma, A. | Inoue, Y. | +33

CommentIn: Am J Respir Crit Care Med. 2020 May 1;201(9):1030-1032. - PMID 31978310

9

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study) : a randomised, placebo-controlled study

enthalten in: The Lancet. Respiratory medicine | 2019

von Maher, T. | Stowasser, S. | Nishioka, Y. | +101

CommentIn: Lancet Respir Med. 2019 Sep;7(9):725-727. - PMID 31326318

10

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis

enthalten in: The New England journal of medicine | 2019

von Tazawa, R. | Ueda, T. | Abe, M. | +29

CommentIn: N Engl J Med. 2020 Jan 9;382(2):197. - PMID 31914249